Annual Drug Patent Expirations for DROSPIRENONE
Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex, Lupin Ltd, Mayne Pharma, Naari Pte Ltd, and Watson Labs Inc and, and is included in twenty NDAs. There are twelve patents protecting this drug.
This drug has fifty-one patent family members in twenty-nine countries.
The generic ingredient in DROSPIRENONE is drospirenone; ethinyl estradiol; levomefolate calcium. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
